R&D News | pharmaphorum

News

Biogen's former R&D chief Al Sandrock resurfaces at Voyager

Al Sandrock's shock departure from Biogen in November sparked speculation about where he would show up next, and the answer came in today – gene therapy specialist Voyager Therapeutics.

News

Can Moderna's mRNA tech overcome the HIV vaccine roadblock?

Moderna has kicked off a clinical trial of an HIV vaccine based on the same mRNA platform that underpins its COVID-19 shot – seeking to succeed where traditional vaccine technologies have f

News

group of chemical scientists working at the laboratory.

Pharming preps filing for rare disease drug leniolisib after...

Pharming has taken a step closer to getting a second product to market, after its rare disease therapy leniolisib met its objectives in a pivotal trial, setting up regulatory filings in the

News

Clear COVID health information essential for a return to healthcare as normal

Omicron BA.2 variant more transmissible, say UK and Danish s...

The new BA.2 subvariant of Omicron is around 50% more transmissible than the original BA.1 strain, and there is somewhat conflicting evidence on its ability to evade the protection from vac

News

Madrigal sings praises of NASH drug resmetirom

After a phase 3 trial win, Madrigal Pharmaceuticals reckons it could succeed where so many other companies have failed, and finally bring a drug to market to treat the liver disease non-alc

News

Daiichi makes play for share of Japan's COVID booster market

Daiichi Sankyo has stepped up its efforts to bring a Japanese COVID-19 vaccine to patients, starting a new clinical trial of its mRNA-based candidate DS-5670 that focuses on its use as a bo

Biogen's former R&D chief Al Sandrock resurfaces at Voyager

Can Moderna's mRNA tech overcome the HIV vaccine roadblock?

Pharming preps filing for rare disease drug leniolisib after...

Omicron BA.2 variant more transmissible, say UK and Danish s...

Madrigal sings praises of NASH drug resmetirom

Daiichi makes play for share of Japan's COVID booster market

Danco fights back after US court curbs abortion pill access

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks